MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
Clinical trial NCT06050707 · RECRUITING
Trial details
- NCT number
- NCT06050707
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-29
- Primary completion
- 2028-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.